1 janv. 2001 - Imatinib Mesylate
Description:
Results of a clinical trial show that the drug imatinib mesylate is effective against chronic myelogenous leukemia (CML), which targets a unique protein produced by the Philadelphia chromosome.
Ajouté au bande de temps:
Date: